聚焦伯恩斯坦_中国制药与生物科技政策逆风及其对估值的影响(英)。See the Disclosure Appendix of this report for required disclosures, analyst certifications and other important information. Alternatively, visit our Global Research Disclosure Website.EXHIBIT 5: China's participation in US licensing transactions has increased meaningfully since 2021。
聚焦伯恩斯坦_中国制药与生物科技政策逆风及其对估值的影响(英)。See the Disclosure Appendix of this report for required disclosures, analyst certifications and other important information. Alternatively, visit our Global Research Disclosure Website.EXHIBIT 5: China's participation in US licensing transactions has increased meaningfully since 2021。
聚焦伯恩斯坦_中国制药与生物科技政策逆风及其对估值的影响(英)。See the Disclosure Appendix of this report for required disclosures, analyst certifications and other important information. Alternatively, visit our Global Research Disclosure Website.EXHIBIT 5: China's participation in US licensing transactions has increased meaningfully since 2021。
覆盖 2026 年,全文共 20 页。
本报告为付费报告,可在资料宝站内下单后获取完整内容。
重点分析了制药、政策等议题。